GBA1 and Parkinson disease: In this scenario, our study aims to deeply investigate the neuropsychological profiles of PD carriers of a GBA1 mutation (PD-GBA+) versus non carriers (PD-GBA−) with a short disease duration through a comprehensive II Level neuropsychological assessment.